News

Filter

Current filters:

None

7875 to 7884 of 95974 results

Celgene makes $15 million investment in Acetylon

10-02-2012

US biotech Celgene (Nasdaq: CELG) will invest a total of $15 million in Acetylon Pharmaceuticals via…

Acetylon PharmaceuticalsBiotechnologyCelgeneFinancial

LEO Pharma sales reps file suit on overtime in USA

09-02-2012

Attorneys from Sanford Wittels & Heisler have filed a class action complaint in the US District Court…

LegalLEO PharmaManagementNorth AmericaPharmaceutical

New low cost HIV drug to be made by Ugandan company

09-02-2012

Starting as early as next month, Uganda will produce a new low cost and more effective life saving HIV/AIDS…

Anti-viralsGenericsMarkets & MarketingRest of the WorldTenofovir Disoproxil Fumarate

Generics will drive Australia’s PBS saving in 2012, says GMiA

09-02-2012

Australian patients and taxpayers need to make the most of the unprecedented value of medicines coming…

Asia-PacificFinancialGenericsHealthcare

Global peptic ulcer market forecast to reach $1.05 billion by 2018; FDA warns on PPIs

09-02-2012

The global peptic ulcer therapeutics market was worth $892.4 million in 2010, and is forecast to grow…

Gastro-intestinalsMarkets & MarketingPharmaceuticalRegulation

Amgen fails to get FDA advisory backing for extended use of Xgeva

09-02-2012

The world’s largest independent biotech firm, Amgen (Nasdaq: AMGN), has failed to convince a Food…

AmgenBiotechnologyNorth AmericaOncologyPharmaceuticalRegulationXgeva

Positive Ph II results for Genzyme’s oral Gaucher drug

09-02-2012

French drug major Sanofi’s (Euronext: SAN) US subsidiary Genzyme yesterday revealed four-year follow-up…

BiotechnologyeliglustatGenzymePharmaceuticalRare diseasesResearchSanofi

More strong data on Forest and Richter antipsychotic cariprazine

09-02-2012

US drugmaker Forest Laboratories (NYSE: FRX) has announced positive preliminary top-line results from…

cariprazineForest LaboratoriesGedeon RichterNeurologicalPharmaceuticalResearch

Elan back in the black, boosted by Tysabri

09-02-2012

Ireland headquartered biotech company Elan Corp (LSE: ELN) has reported its fourth-quarter 2011 results…

BiotechnologyElanFinancialTysabri

7875 to 7884 of 95974 results

Back to top